Keeping RAASi Treatment With Optimal Potassium Control
NCT06578533
·
clinicaltrials.gov ↗
PHASE3
Phase
RECRUITING
Status
78
Enrollment
OTHER
Sponsor class
Conditions
Chronic Kidney Diseases
Interventions
DRUG:
Sodium Zirconium Cyclosilicate
Sponsor
Fundación para la Investigación del Hospital Clínico de Valencia